BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12531976)

  • 1. Anti-titin antibodies are not associated with a specific thymoma histology.
    Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 3. Sera from myasthenia gravis patients recognize the PEVK domain of titin.
    Mihovilovic M; Mai Y; Austin C; Roses AD
    Ann N Y Acad Sci; 1998 May; 841():534-7. PubMed ID: 9668289
    [No Abstract]   [Full Text] [Related]  

  • 4. Titin transcripts in thymomas.
    Skeie GO; Freiburg A; Kolmerer B; Labeit S; Aarli JA; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():422-6. PubMed ID: 9668270
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.
    Aarli JA; Skeie GO; Mygland A; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():505-15. PubMed ID: 9668283
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
    J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
    Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
    Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
    Skeie GO; Pandey JP; Aarli JA; Gilhus NE
    Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
    Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titin, thymoma, and myasthenia gravis.
    Aarli JA
    Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
    [No Abstract]   [Full Text] [Related]  

  • 14. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
    Buckley C; Newsom-Davis J; Willcox N; Vincent A
    Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma].
    Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu
    Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
    Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
    J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations.
    Skeie GO; Mygland A; Aarli JA; Gilhus NE
    Autoimmunity; 1995; 20(2):99-104. PubMed ID: 7578874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.